Annovis Bio
ANVS
ANVS
53 hedge funds and large institutions have $14.7M invested in Annovis Bio in 2025 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 17 increasing their positions, 2 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
26% more funds holding
Funds holding: 42 → 53 (+11)
5.6% more ownership
Funds ownership: 10.39% → 15.99% (+5.6%)
Holders
53
Holding in Top 10
–
Calls
$2.01M
Puts
$768K
Top Buyers
| 1 | +$2.18M | |
| 2 | +$1.66M | |
| 3 | +$755K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$557K |
| 5 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$483K |
Top Sellers
| 1 | -$524K | |
| 2 | -$77K | |
| 3 | -$59.7K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$21.8K |
| 5 |
GWM
Greenwich Wealth Management
Greenwich,
Connecticut
|
-$15K |
